🔴 Intravenous Infusions is trading 9.86% down today after profit-taking

Intravenous Infusions is trading at GHS 0.64, down 9.86%, as profit-taking and short-term trading dynamics drive the pullback.

• The decline follows several volatile sessions and a sharp rally through late July.
• No reliable August 7, 2026 company-specific announcement was identified; earlier momentum was described as speculative.
• The broader U.S. market was modestly higher before the open, so global sentiment does not clearly explain the decline. [Hero News ID: 6a7468cbd74844272dd16a59]